Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Adicionar filtros








Intervalo de ano
1.
Braz. j. med. biol. res ; 39(7): 895-899, July 2006. ilus, tab, graf
Artigo em Inglês | LILACS | ID: lil-431554

RESUMO

Trypanosoma cruzi infection and nonsteroidal anti-inflammatory drugs inhibit colorectal carcinogenesis by mechanisms not completely known and metallothionein proteins (MTs) may be involved in this process. Sixty-six male Wistar rats weighing 90 to 120 g were randomly divided into seven groups (GI to GVII). GI, GII and GIII animals were subcutaneously infected with 200,000 trypomastigote forms of the Y strain of T. cruzi. After 8 weeks, GI, GII, GIV, and GVI were injected with one weekly subcutaneous dose of 12 mg/kg dimethylhydrazine for 4 weeks. In sequence, GI, GIV and GV were treated with nimesulide (10 mg/kg per dose, five times per week for 8 weeks). Groups I, III, IV, and VI had 12 animals, and each of the other groups had 6 animals. All the animals were euthanized 8 weeks after the last dimethylhydrazine injection. The colons were fixed and processed for MT immunohistochemistry. The index of MT-overexpressing colonic crypts (MTEC) was estimated as the percentage of MT-stained crypts in relation to the total number of crypts scored. Five hundred crypts per animal were scored. Data were analyzed by the Kruskal-Wallis test followed by the Dunn test. There was an increase in MTEC index in the groups either infected with T. cruzi or treated with nimesulide or both infected and treated when compared to control (401, 809, and 1011 percent, respectively). We suggest that the increased formation of MTEC may be related to the protection against carcinogenesis provided both by T. cruzi infection and nimesulide.


Assuntos
Animais , Masculino , Ratos , Anti-Inflamatórios não Esteroides/farmacologia , Doença de Chagas/congênito , Neoplasias Colorretais/metabolismo , Metalotioneína/metabolismo , Sulfonamidas/farmacologia , Carcinógenos , Neoplasias Colorretais/complicações , Neoplasias Colorretais/prevenção & controle , Dimetilidrazinas , Modelos Animais de Doenças , Imuno-Histoquímica , Metalotioneína/efeitos dos fármacos , Ratos Wistar
2.
Zagazig University Medical Journal. 2001; 7 (1): 149-63
em Inglês | IMEMR | ID: emr-58703

RESUMO

Zinc-metallothionein [MT] is a low molecular weight [MW] zinc binding protein [600-700 Dalton]. MT has been proposed to participate in the transport, accumulation, and compartmentation of zinc in the biological system In addition to its role as a storehouse for zinc, MT acts as a free radical scavenger and protect against cadmium toxicity. The present work aimed to investigate the possible role of MT in providing a myocardial protection against isoprenaline-induced myocardial infarction [MI] and arrhythmias in rabbits. To induce myocardial MT, zinc sulfate was injected intraperitoneally 50mg/kg for three consecutive days. It was found that MT protected against MI as indicated by the lower levels of creatine kinase-MB, aspertate aminotransferase and lactate dehydrogenase enzymes. It has also potentiated verapamil effect to protect against tachyarrhythmias


Assuntos
Animais de Laboratório , Metalotioneína/efeitos dos fármacos , Compostos de Zinco/efeitos dos fármacos , Substâncias Protetoras , Arritmias Cardíacas , Coelhos
3.
Experimental & Molecular Medicine ; : 32-36, 2001.
Artigo em Inglês | WPRIM | ID: wpr-31944

RESUMO

Metallothioneins (MT), small molecular weight metal binding proteins are known to play an important protective role against heavy metal toxicity, either as antioxidants or pre-oxidants. However, the mode of metabolic fate of MTs in various metal complexes is not clearly understood. This study was carried out to better understand the mode of selective turnover rate of various form of MT in complexes with different metals. The degradation of in vitro translated mouse 35S-cysteine-MT was examined in lysosomal or cytosolic fractions from mouse liver by gel electrophoresis and autoradiography. Overnight incubations of MT showed extensive proteolysis in the lysosomal fraction but not in cytosolic fractions. However, Cu2+-MT was found to be stable under the same experimental condition. In contrast, Zn did not interfere with MT degradation. These results suggest that lysosomes are chiefly responsible for MT removal and appears to be selective on the metals involved in the MT complex. In vitro, translated, radiolabeled MT provides a suitable substrate for investigating the characteristics of MT degradation.


Assuntos
Camundongos , Animais , Cobre/metabolismo , Íons , Fígado/efeitos dos fármacos , Lisossomos/metabolismo , Metalotioneína/efeitos dos fármacos , Radioisótopos de Enxofre , Zinco/metabolismo
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA